SBF 120
5.619,26
PKT
-46,52
PKT
-0,82
%
Werbung
Analysen zu SBF 120-Werten
Datum | Rating | Analyst | |
---|---|---|---|
10.02.16 | Engie (ex GDF Suez) buy | Citigroup Corp. | |
10.02.16 | Vivendi Outperform | Macquarie Research | |
10.02.16 | VINCI Halten | Independent Research GmbH | |
10.02.16 | Vivendi Halten | Independent Research GmbH | |
10.02.16 | Renault Outperform | Credit Suisse Group | |
10.02.16 | Schneider Electric Hold | Kepler Cheuvreux | |
10.02.16 | LOréal Neutral | JP Morgan Chase & Co. | |
10.02.16 | Engie (ex GDF Suez) buy | UBS AG | |
10.02.16 | Sanofi buy | Société Générale Group S.A. (SG) | |
10.02.16 | Sanofi Underweight | JP Morgan Chase & Co. | |
09.02.16 | Sanofi buy | S&P Capital IQ | |
09.02.16 | BNP Paribas Conviction Buy | Goldman Sachs Group Inc. | |
09.02.16 | Unibail-Rodamco Neutral | JP Morgan Chase & Co. | |
09.02.16 | Schneider Electric Neutral | BNP PARIBAS | |
09.02.16 | Unibail-Rodamco buy | Société Générale Group S.A. (SG) | |
08.02.16 | Vivendi overweight | Morgan Stanley | |
08.02.16 | BNP Paribas overweight | Morgan Stanley | |
08.02.16 | BNP Paribas Equal weight | Barclays Capital | |
08.02.16 | Airbus Equal-Weight | Morgan Stanley | |
08.02.16 | Airbus buy | Kepler Cheuvreux | |
08.02.16 | VINCI buy | Kepler Cheuvreux | |
08.02.16 | BNP Paribas Hold | Kepler Cheuvreux | |
08.02.16 | Holcim Outperform | Credit Suisse Group | |
08.02.16 | Saint-Gobain Underperform | Credit Suisse Group | |
08.02.16 | VINCI overweight | JP Morgan Chase & Co. | |
08.02.16 | Sanofi Underweight | JP Morgan Chase & Co. | |
08.02.16 | BNP Paribas Underweight | JP Morgan Chase & Co. | |
08.02.16 | VINCI buy | UBS AG | |
08.02.16 | VINCI buy | HSBC | |
05.02.16 | Schneider Electric Neutral | Goldman Sachs Group Inc. | |
05.02.16 | Engie (ex GDF Suez) Halten | Independent Research GmbH | |
05.02.16 | Danone overweight | Morgan Stanley | |
05.02.16 | VINCI overweight | JP Morgan Chase & Co. | |
05.02.16 | Unibail-Rodamco buy | HSBC | |
05.02.16 | BNP Paribas buy | S&P Capital IQ | |
05.02.16 | BNP Paribas buy | S&P Capital IQ | |
05.02.16 | VINCI Hold | S&P Capital IQ | |
05.02.16 | VINCI buy | UBS AG | |
05.02.16 | Sanofi Neutral | UBS AG | |
04.02.16 | Vivendi overweight | Morgan Stanley |